Prime Medicine Etf Forecast - Polynomial Regression
| PRME Etf | USD 4.28 0.10 2.39% |
Prime Etf outlook is based on your current time horizon. Investors can use this forecasting interface to forecast Prime Medicine stock prices and determine the direction of Prime Medicine Common's future trends based on various well-known forecasting models. We recommend always using this module together with an analysis of Prime Medicine's historical fundamentals, such as revenue growth or operating cash flow patterns.
At the present time, The RSI of Prime Medicine's share price is at 52 indicating that the etf is in nutural position, most likellhy at or near its resistance level. The main idea of RSI analysis is to track how fast people are buying or selling Prime Medicine, making its price go up or down. Momentum 52
Impartial
Oversold | Overbought |
EPS Estimate Next Quarter (0.20) | EPS Estimate Current Year (1.28) | EPS Estimate Next Year (0.90) | Wall Street Target Price 6.4643 | EPS Estimate Current Quarter (0.25) |
Using Prime Medicine hype-based prediction, you can estimate the value of Prime Medicine Common from the perspective of Prime Medicine response to recently generated media hype and the effects of current headlines on its competitors. We also analyze overall investor sentiment towards Prime Medicine using Prime Medicine's stock options and short interest. It helps to benchmark the overall future attitude of investors towards Prime using crowd psychology based on the activity and movement of Prime Medicine's stock price.
Prime Medicine Implied Volatility | 1.46 |
Prime Medicine's implied volatility exposes the market's sentiment of Prime Medicine Common stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Prime Medicine's implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Prime Medicine stock will not fluctuate a lot when Prime Medicine's options are near their expiration.
The Polynomial Regression forecasted value of Prime Medicine Common on the next trading day is expected to be 4.30 with a mean absolute deviation of 0.22 and the sum of the absolute errors of 13.78. Prime Medicine after-hype prediction price | USD 4.28 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as etf price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Check out Historical Fundamental Analysis of Prime Medicine to cross-verify your projections. Prediction based on Rule 16 of the current Prime contract
Based on the Rule 16, the options market is currently suggesting that Prime Medicine Common will have an average daily up or down price movement of about 0.0913% per day over the life of the 2026-04-17 option contract. With Prime Medicine trading at USD 4.28, that is roughly USD 0.003906 . If you think that the market is fully incorporating Prime Medicine's daily price movement you should consider acquiring Prime Medicine Common options at the current volatility level of 1.46%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
Open Interest Against 2026-04-17 Prime Option Contracts
Although open interest is a measure utilized in the options markets, it could be used to forecast Prime Medicine's spot prices because the number of available contracts in the market changes daily, and new contracts can be created or liquidated at will. Since open interest in Prime Medicine's options reflects these daily shifts, investors could use the patterns of these changes to develop long and short-term trading strategies for Prime Medicine stock based on available contracts left at the end of a trading day.
Please note that to derive more accurate forecasting about market movement from the current Prime Medicine's open interest, investors have to compare it to Prime Medicine's spot prices. As Ford's stock price increases, high open interest indicates that money is entering the market, and the market is strongly bullish. Conversely, if the price of Prime Medicine is decreasing and there is high open interest, that is a sign that the bearish trend will continue, and investors may react by taking short positions in Prime. So, decreasing or low open interest during a bull market indicates that investors are becoming uncertain of the depth of the bullish trend, and a reversal in sentiment will likely follow.
Prime Medicine Additional Predictive Modules
Most predictive techniques to examine Prime price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Prime using various technical indicators. When you analyze Prime charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Prime Medicine Polynomial Regression Price Forecast For the 29th of January
Given 90 days horizon, the Polynomial Regression forecasted value of Prime Medicine Common on the next trading day is expected to be 4.30 with a mean absolute deviation of 0.22, mean absolute percentage error of 0.08, and the sum of the absolute errors of 13.78.Please note that although there have been many attempts to predict Prime Etf prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Prime Medicine's next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
Prime Medicine Etf Forecast Pattern
| Backtest Prime Medicine | Prime Medicine Price Prediction | Buy or Sell Advice |
Prime Medicine Forecasted Value
In the context of forecasting Prime Medicine's Etf value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Prime Medicine's downside and upside margins for the forecasting period are 0.04 and 10.28, respectively. We have considered Prime Medicine's daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Polynomial Regression forecasting method's relative quality and the estimations of the prediction error of Prime Medicine etf data series using in forecasting. Note that when a statistical model is used to represent Prime Medicine etf, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | 117.4553 |
| Bias | Arithmetic mean of the errors | None |
| MAD | Mean absolute deviation | 0.2223 |
| MAPE | Mean absolute percentage error | 0.0573 |
| SAE | Sum of the absolute errors | 13.781 |
Predictive Modules for Prime Medicine
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Prime Medicine Common. Regardless of method or technology, however, to accurately forecast the etf market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the etf market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Prime Medicine After-Hype Price Density Analysis
As far as predicting the price of Prime Medicine at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Prime Medicine or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Etf prices, such as prices of Prime Medicine, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Prime Medicine Estimiated After-Hype Price Volatility
In the context of predicting Prime Medicine's etf value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Prime Medicine's historical news coverage. Prime Medicine's after-hype downside and upside margins for the prediction period are 0.21 and 10.23, respectively. We have considered Prime Medicine's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Prime Medicine is very risky at this time. Analysis and calculation of next after-hype price of Prime Medicine Common is based on 3 months time horizon.
Prime Medicine Etf Price Outlook Analysis
Have you ever been surprised when a price of a ETF such as Prime Medicine is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Prime Medicine backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Etf price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Prime Medicine, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.14 | 5.98 | 0.05 | 0.02 | 3 Events / Month | 7 Events / Month | In about 3 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
4.28 | 4.28 | 0.00 |
|
Prime Medicine Hype Timeline
Prime Medicine Common is at this time traded for 4.28. The entity has historical hype elasticity of -0.05, and average elasticity to hype of competition of -0.02. Prime is expected not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is over 100%. The immediate return on the next news is expected to be very small, whereas the daily expected return is at this time at 0.14%. %. The volatility of related hype on Prime Medicine is about 5387.39%, with the expected price after the next announcement by competition of 4.26. About 18.0% of the company outstanding shares are owned by corporate insiders. The book value of Prime Medicine was at this time reported as 0.92. The company recorded a loss per share of 1.42. Given the investment horizon of 90 days the next expected press release will be in about 3 days. Check out Historical Fundamental Analysis of Prime Medicine to cross-verify your projections.Prime Medicine Related Hype Analysis
Having access to credible news sources related to Prime Medicine's direct competition is more important than ever and may enhance your ability to predict Prime Medicine's future price movements. Getting to know how Prime Medicine's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Prime Medicine may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| MRVI | Maravai Lifesciences Holdings | (0.39) | 18 per month | 3.19 | 0.04 | 8.38 | (6.35) | 20.24 | |
| KURA | Kura Oncology | (0.39) | 3 per month | 0.00 | (0.04) | 6.59 | (5.06) | 22.27 | |
| BCAX | Bicara Therapeutics Common | 0.45 | 7 per month | 3.39 | 0.01 | 6.05 | (6.63) | 18.88 | |
| VIR | Vir Biotechnology | (0.39) | 10 per month | 3.81 | 0.08 | 8.08 | (6.25) | 20.46 | |
| REPL | Replimune Group | (0.09) | 9 per month | 0.00 | (0.04) | 5.56 | (5.32) | 20.44 | |
| SEPN | Septerna Common Stock | (0.39) | 3 per month | 2.85 | 0.05 | 7.41 | (4.82) | 27.95 | |
| TYRA | Tyra Biosciences | 0.51 | 9 per month | 1.58 | 0.28 | 6.05 | (2.98) | 34.11 | |
| PROK | ProKidney Corp | (0.39) | 9 per month | 0.00 | (0.11) | 5.77 | (8.95) | 22.38 | |
| RZLT | Rezolute | 0.36 | 9 per month | 15.49 | 0.03 | 18.05 | (9.22) | 99.29 | |
| EYPT | Eyepoint Pharmaceuticals | (0.39) | 25 per month | 3.30 | 0.12 | 7.21 | (4.89) | 22.25 |
Other Forecasting Options for Prime Medicine
For every potential investor in Prime, whether a beginner or expert, Prime Medicine's price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Prime Etf price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Prime. Basic forecasting techniques help filter out the noise by identifying Prime Medicine's price trends.Prime Medicine Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Prime Medicine etf to make a market-neutral strategy. Peer analysis of Prime Medicine could also be used in its relative valuation, which is a method of valuing Prime Medicine by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Prime Medicine Market Strength Events
Market strength indicators help investors to evaluate how Prime Medicine etf reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Prime Medicine shares will generate the highest return on investment. By undertsting and applying Prime Medicine etf market strength indicators, traders can identify Prime Medicine Common entry and exit signals to maximize returns.
Prime Medicine Risk Indicators
The analysis of Prime Medicine's basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Prime Medicine's investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting prime etf prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 4.55 | |||
| Standard Deviation | 5.87 | |||
| Variance | 34.49 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Prime Medicine
The number of cover stories for Prime Medicine depends on current market conditions and Prime Medicine's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Prime Medicine is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Prime Medicine's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Prime Medicine Short Properties
Prime Medicine's future price predictability will typically decrease when Prime Medicine's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Prime Medicine Common often depends not only on the future outlook of the potential Prime Medicine's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Prime Medicine's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 118.6 M | |
| Cash And Short Term Investments | 190.4 M |
Other Information on Investing in Prime Etf
Prime Medicine financial ratios help investors to determine whether Prime Etf is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Prime with respect to the benefits of owning Prime Medicine security.